Fig. 2.
Fig. 2. HIV-1 viral load in plasma ([•] 104 copies/mL), absolute CD4+ T-cell counts ([▵] cells per microliter), and CD95L-mRNA levels in freshly isolated T cells ([○] femtograms per 250 ng total RNA) during antiretroviral combination therapy with zidovudine and didanosine in an HIV-1+ infant. Initial reduction of HIV-1 viral load and CD95L-mRNA levels were paralleled by an increase in CD4+ T-cell counts. However, as early as 12 weeks after the introduction of antiretroviral treatment, HIV-1 viral load and CD95L-mRNA levels increased and CD4+ T-cell counts decreased.

HIV-1 viral load in plasma ([•] 104 copies/mL), absolute CD4+ T-cell counts ([▵] cells per microliter), and CD95L-mRNA levels in freshly isolated T cells ([○] femtograms per 250 ng total RNA) during antiretroviral combination therapy with zidovudine and didanosine in an HIV-1+ infant. Initial reduction of HIV-1 viral load and CD95L-mRNA levels were paralleled by an increase in CD4+ T-cell counts. However, as early as 12 weeks after the introduction of antiretroviral treatment, HIV-1 viral load and CD95L-mRNA levels increased and CD4+ T-cell counts decreased.

Close Modal

or Create an Account

Close Modal
Close Modal